Package 42192-614-30

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "ae14cce7-f65a-45e0-8ff4-9388d0a806d2", "openfda": {"unii": ["4182431BJH"], "rxcui": ["1670351", "1670353"], "spl_set_id": ["6922f32f-8bed-4c09-8103-27987bcbd104"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (42192-614-10)  / 2 mL in 1 VIAL", "package_ndc": "42192-614-10", "marketing_start_date": "20211230"}, {"sample": false, "description": "10 VIAL in 1 CARTON (42192-614-30)  / 5 mL in 1 VIAL", "package_ndc": "42192-614-30", "marketing_start_date": "20211230"}], "brand_name": "PHENYTOIN SODIUM", "product_id": "42192-614_ae14cce7-f65a-45e0-8ff4-9388d0a806d2", "dosage_form": "INJECTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "42192-614", "generic_name": "PHENYTOIN SODIUM", "labeler_name": "Acella Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHENYTOIN SODIUM", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA040573", "marketing_category": "ANDA", "marketing_start_date": "20211201", "listing_expiration_date": "20261231"}